Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 23.40%
March 31, 2026 21.32%
December 31, 2025 22.42%
September 30, 2025 20.17%
June 30, 2025 21.72%
March 31, 2025 21.90%
December 31, 2024 22.46%
September 30, 2024 12.04%
June 30, 2024 28.90%
March 31, 2024 32.95%
December 31, 2023 22.62%
September 30, 2023 31.95%
June 30, 2023 25.55%
March 31, 2023 31.69%
December 31, 2022 50.76%
September 30, 2022 30.85%
June 30, 2022 27.26%
March 31, 2022 26.88%
December 31, 2021 18.57%
September 30, 2021 30.40%
June 30, 2021 26.93%
March 31, 2021 24.97%
December 31, 2020 20.50%
September 30, 2020 15.52%
June 30, 2020 32.30%
Date Value
March 31, 2020 22.84%
December 31, 2019 24.53%
September 30, 2019 22.76%
June 30, 2019 27.46%
March 31, 2019 20.78%
December 31, 2018 27.16%
September 30, 2018 29.41%
June 30, 2018 31.24%
March 31, 2018 27.55%
December 31, 2017 28.42%
September 30, 2017 28.54%
June 30, 2017 30.23%
March 31, 2017 30.39%
December 31, 2016 33.86%
September 30, 2016 27.82%
June 30, 2016 28.35%
March 31, 2016 28.95%
December 31, 2015 25.06%
September 30, 2015 19.50%
June 30, 2015 26.63%
March 31, 2015 31.14%
December 31, 2014 15.71%
September 30, 2014 18.14%
June 30, 2014 18.99%
March 31, 2014 51.41%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Hansa Biopharma AB -541.7%
BioArctic AB -4.51%
Swedish Orphan Biovitrum AB 14.00%
Diamyd Medical AB -25.84K%
BONESUPPORT HOLDING AB 23.02%